MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze MDT →
    • FindStock Picks / Stock Screener
    • Value · MDTIntrinsic Value Calculator
    • Invest · MDTInvestment Case
    • Hold · MDT5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
MDT stock logo

MDT

Medtronic Plc

$99.94
-0.67
 (-0.67%)
Exchange:  NYSE
Market Cap:  127.84B
Shares Outstanding:  1.282B
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – DevicesView industry performance
   
CEO:  Geoffrey Straub Martha
Full Time Employees:  95000
Address: 
Building Two, Parkmore Business Park West
Galway
GA
H91 4K49
IE
Website:  https://www.medtronic.com
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company’s operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain’s vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Click to read more…

Revenue Segmentation

Revenue by type

Revenue by region

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

MDT full analysis

05/06/2026

Hey everyone, welcome back to the channel. Today we're diving deep into Medtronic, ticker MDT, one of the biggest names in medical devices, and breaking down whether this stock deserves a spot in your portfolio right now. Medtronic just wrapped up what management is calling its best year in a decade, and the stock has been reacting to that momentum mixed with some sector headwinds. We're going to look at the numbers, the growth drivers, valuation, and what the setup…

Listen to full analysis (audio file)

Open in MarketSnap Listen

Log in to continue

Log in to see the full analysis preview and audio links.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
MDMDT logoMDTMedtronic Plc127.8B24.518.16.4%
SYSYK logoSYKStryker Corporation118.0B32.820.99.5%
ABABT logoABTAbbott Laboratories178.4B38.118.75.5%
BSBSX logoBSXBoston Scientific Corporation60.8B17.713.310.5%
EWEW logoEWEdwards Lifesciences Corporation58.6B57.533.79.1%
GEGEHC logoGEHCGE HealthCare Technologies Inc.36.5B17.016.17.8%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/09/01 — Q1 quarter 2027

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202420252026
Revenue32,364,00033,537,00036,364,000
Gross Profit21,148,00021,905,00023,643,000
EBITDA8,203,0009,218,0009,809,000
Operating Income5,144,0005,955,0006,467,000
Net Income3,676,0004,662,0004,800,000

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202420252026
Total Assets89,981,00091,680,00093,028,000
Total Liabilities39,561,00043,424,00042,956,000
Total Stockholders Equity50,214,00048,024,00049,463,000
Total Debt25,024,00028,516,00027,961,000
Cash and Cash Equivalents1,284,0002,218,0001,949,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202420252026
Operating Cash Flow6,787,0007,044,0007,330,000
Capital Expenditure-1,587,000-1,859,000-1,904,000
Free Cash Flow5,200,0005,185,0005,426,000
Net Income3,676,0004,691,0004,837,000
Net Change in Cash-259,000934,000-269,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2031Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)43,208,483.225Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)46,875,367.976Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)45,992,500Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)15,171,916.530Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)16,527,222.653Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)16,200,910.831Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)9,600,711.666Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)10,680,770.636Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)10,420,729.008Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)14,151,767.893Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)15,352,756.635Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)15,063,597.152Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)8.090Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)8.290Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)7.450Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)6Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)3Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
32.364B  ?P/S
 (TTM)
: 
3.41
?Net Income
 (TTM)
: 
3.676B  ?P/E
 (TTM)
: 
24.5
?Enterprise Value
 (TTM)
: 
154.302B  ?EV/FCF
 (TTM)
: 
25.16
?Dividend Yield
 (TTM)
: 
2.86%  ?Payout Ratio
 (TTM)
: 
69.79%
?ROE
 (TTM)
: 
10.6%  ?ROIC
 (TTM)
: 
6.44%
?Net Debt
 (TTM)
: 
18.685B  ?Debt/Equity
 (TTM)
: 
0.56
?P/B
 (TTM)
: 
2.55  ?Current Ratio
 (TTM)
: 
2.07

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
18.11Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

Strengths (preview)

  • Delivered 4.1% organic revenue growth in fiscal Q3 2025, exceeding analyst expectations through operational execution.
  • Positioned for sustained performance via targeted strategic investments and product innovation in core medical technology segments.
  • Maintains a diversified revenue base across product categories and geographic regions, supporting resilience in the healthcare sector.

Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.

Log in to continue

Log in with Research Access for the complete SWOT analysis.

Create a free account

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates MDT intrinsic value between $92.44 – $112.24 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate MDT Intrinsic Value

Common questions about MDT valuation

Is Medtronic Plc (MDT) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for Medtronic Plc (MDT) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is MDT a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether MDT trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is MDT’s P/E ratio?

You can see MDT’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for MDT?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is MDT a good long-term investment?

Whether MDT fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for Medtronic Plc

  • Medtronic Plc intrinsic value calculatorEstimate what the business is worth
  • Medtronic Plc 5-year outlookWhat has to go right, and what could go wrong
MDT

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-0.67
MarketSnap

Trading Metrics:

Open: 101.46   Previous Close: 100.61
Day Low: 99.59   Day High: 102.61
Year Low: 73.31   Year High: 106.33
Price Avg 50: 94.45   Price Avg 200: 88.24
Volume: 8.919M   Average Volume: 13.782M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

Ahead of Medtronic (MDT) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
19-11-2026 10:16
Ahead of Medtronic (MDT) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Should You Continue to Hold Medtronic Stock in Your Portfolio?
18-11-2026 09:26
Should You Continue to Hold Medtronic Stock in Your Portfolio?
Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system
17-11-2026 06:00
Medtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system
3 Dividend Stocks That Don’t Need a Booming Economy to Keep Paying
16-11-2026 09:47
3 Dividend Stocks That Don’t Need a Booming Economy to Keep Paying
Medtronic Kept Growing When All Eyes Were On AI, Time To Give This Growth Justice
12-11-2026 02:45
Medtronic Kept Growing When All Eyes Were On AI, Time To Give This Growth Justice
Medtronic Has Raised Its Dividend for 49 Years. These 2 Rivals Have Even Longer Streaks
27-10-2026 13:49
Medtronic Has Raised Its Dividend for 49 Years. These 2 Rivals Have Even Longer Streaks

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Pricing

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze MDT →
    • FindStock Picks / Stock Screener
    • Value · MDTIntrinsic Value Calculator
    • Invest · MDTInvestment Case
    • Hold · MDT5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Plans
    • Settings
    • Public profile ↗
  • Log in
  • Log out

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.